Skip to main content
Clinical Trials/NCT07658014
NCT07658014CompletedNot Applicable

Initial Diastolic Shock Index and Lactate as Predictors of Occult Vasoplegia in Normotensive Sepsis.

Hospital H+ Queretaro1 site in 1 country526 target enrollmentStarted: January 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
526
Locations
1

Study Overview

Brief Summary

The goal of this observational study is to learn if the Diastolic Shock Index (DSI) and initial lactate can predict occult vasoplegia in adults with normotensive sepsis. Normotensive sepsis occurs in patients who have an apparently normal mean arterial pressure but may have impaired vascular tone.

The main questions it aims to answer are:

  • Can an elevated DSI at admission predict the initiation of vasopressors (norepinephrine) within the first 6 hours of intensive care unit stay?
  • How does the combination of initial DSI and lactate perform compared to each marker alone in predicting hemodynamic deterioration? Researchers will compare patients with an elevated DSI to those with a normal DSI to see if this index identifies those who will progress to circulatory shock.Since this is a retrospective cohort study using existing medical records, participants will not be asked to perform any tasks. Researchers will analyze anonymized data, such as heart rate, blood pressure, and lactate levels already recorded in the institutional database.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients over 18 years of age.
  • Diagnosis of sepsis upon admission according to Sepsis-3 criteria (suspected or confirmed infection plus an increase in SOFA score >2).
  • Mean Arterial Pressure (MAP) during the first hour >=65 mmHg.
  • No vasopressor infusion at the time of initial assessment (Time 0)

Exclusion Criteria

  • Patients who died within the first 24 hours of admission.
  • Patients transferred out of the unit within the first 24 hours
  • Patients who were already receiving vasopressor support in the pre-hospital setting or the emergency department before ICU admission.

Investigators

Sponsor
Hospital H+ Queretaro
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jose J Zaragoza, MD MSc

Amy Sevilla

Hospital H+ Queretaro

Study Sites (1)

Loading locations...

Similar Trials